Korro Bio, Inc. (KRRO) Financials

KRRO Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 183.6 million 64.0 million
Dec. 31, 2025 113.5 million 62.1 million
Sept. 30, 2025 161.6 million 62.5 million
June 30, 2025 180.4 million 65.3 million

KRRO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -16.1 million 2.7 million
Dec. 31, 2025 -17.8 million 2.1 million
Sept. 30, 2025 -17.4 million 1.8 million
June 30, 2025 -19.4 million 2.0 million

KRRO Net Income

No data available :(

KRRO Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 114.0 million 40.1 million -
Dec. 31, 2025 75.2 million - 40.8 million
Sept. 30, 2025 93.5 million - 41.5 million
June 30, 2025 96.4 million - 44.6 million

KRRO Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 11.6 million
Dec. 31, 2025 9.4 million
Sept. 30, 2025 9.4 million
June 30, 2025 9.4 million

KRRO Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 21000 13.0 million 7.5 million -
Dec. 31, 2025 84000 11.0 million 6.2 million -
Sept. 30, 2025 175000 13.8 million 6.5 million -
June 30, 2025 140000 21.0 million 10.3 million 3.4 million

KRRO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 380000
Dec. 31, 2025 1.3 million 649000
Sept. 30, 2025 1.1 million -
June 30, 2025 1.5 million -

KRRO

Price: $12.99

52 week price:
5.20
55.89

Earnings Per Share: -11.68 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 111.3 million

Links: